Supriya Lifescience Limited

NSE:SUPRIYA.NS

648.3 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017
Operating Activities:
Net Income 1,191.141,234.872,072.451,673.93962.27571.0487.28
Depreciation & Amortization 158.11118.06101.1866.7863.7654.3553.32
Deferred Income Tax 0000000
Stock Based Compensation 0000000
Change In Working Capital -171.42-356.39-1,043.53-627.77366.01-67.978
Accounts Receivables -270.19305.19-416.83-218.774.65-65.51-37.89
Inventory 305.21-234.58-198.32-230.22-187.269.6765.17
Accounts Payables -46.59152.56-20.516.5352.6423.7611.38
Other Working Capital -159.85-579.56-407.88-195.38425.98-35.89-30.66
Other Non Cash Items 383.32-334.67-642.09-313.64-231.42-70.793.9
Operating Cash Flow 1,233.36661.87488.01799.31,160.62486.72174.52
Investing Activities:
Investments In Property Plant And Equipment -1,456.55-1,084-599.04-482.41-245.25-69.45-49.3
Acquisitions Net 05.430.8214.40117.092.18
Purchases Of Investments -385-252.43000-117.770
Sales Maturities Of Investments 02470000.680
Other Investing Activites -279.2-247.450.82-6.090117.772.18
Investing Cash Flow -1,841.55-1,331.45-598.22-474.1-245.2548.32-47.12
Financing Activities:
Debt Repayment -166.25-46.7-486.07-116.66-76.28-405.35-97.09
Common Stock Issued 002,0000000
Common Stock Repurchased 00486.070000
Dividends Paid -48.29-48.29-43.91-39.56-176.4600
Other Financing Activities -171.7661.31-459.576.91-39.56-91.8-112.87
Financing Cash Flow -218.08-33.681,496.52-149.31-292.3-497.15-97.09
Other Information:
Effect Of Forex Changes On Cash 000-30.170055.79
Net Change In Cash -24.15-703.261,386.31175.88623.0737.8986.1
Cash At End Of Period 749.561,575.822,279.08922.93747.05123.9827.36